← Back to directory
H
HealthCap
Stockholm, SwedenWebsite ↗
HealthCap is a European venture capital firm that invests globally in life sciences, focusing on breakthrough therapies and innovative companies addressing diseases with high unmet medical needs. Since its inception, the firm has actively fostered the life science ecosystem, contributing to the development of numerous approved pharmaceutical products and medical devices.
Last raised
Apr 2025
1y 3mo ago
Latest fund size
$214M
HealthCap IX
AUM
$1.6B
estimated
Funds raised
Capital this firm has raised, newest first
HealthCap IX
Apr 2025 · HealthCap IX
$214M
HealthCap VIII
Jan 2020 · HealthCap VIII
$248.2M
HealthCap VII
Dec 2016 · HealthCap VII
—
HealthCap VI
Jan 2013 · HealthCap VI
—
HealthCap V
May 2006 · HealthCap V
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| CurifyLabsLead | Series A | $14M | Jul 2026 | |
| NeobiomicsLead | — | — | May 2026 | |
| Adcendo | Series C | — | Apr 2026 | |
| Step Pharma | Series C | $44M | Oct 2025 | |
| Hemab | Series C | $160M | Oct 2025 | |
| Gesynta Pharma AB | Series B | — | Jul 2025 | |
| CellCentric | Series C | $120M | May 2025 | |
| Adcendo | Series B | $140M | Nov 2024 |
Sources
Where this data came from